These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 9433880

  • 21. NOD mice exocrinopathy: towards a neuroimmune link.
    Calafat M, Larocca L, Roca V, Pérez Leirós C.
    Neuroimmunomodulation; 2007; 14(3-4):175-81. PubMed ID: 18073511
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y, Chen LL, Tepavcevic V, Ferdman D, Hodges RR, Dartt DA.
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice.
    Haneji N, Hamano H, Yanagi K, Hayashi Y.
    J Immunol; 1994 Sep 15; 153(6):2769-77. PubMed ID: 8077681
    [Abstract] [Full Text] [Related]

  • 26. IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.
    Nguyen CQ, Gao JH, Kim H, Saban DR, Cornelius JG, Peck AB.
    J Immunol; 2007 Jul 01; 179(1):382-90. PubMed ID: 17579059
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome.
    Robinson CP, Yamachika S, Alford CE, Cooper C, Pichardo EL, Shah N, Peck AB, Humphreys-Beher MG.
    Proc Natl Acad Sci U S A; 1997 May 27; 94(11):5767-71. PubMed ID: 9159148
    [Abstract] [Full Text] [Related]

  • 29. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K.
    Arthritis Rheum; 2006 Jul 27; 54(7):2300-5. PubMed ID: 16802370
    [Abstract] [Full Text] [Related]

  • 30. Elevated proapoptotic Bax and caspase 3 activation in the NOD.scid model of Sjögren's syndrome.
    Masago R, Aiba-Masago S, Talal N, Zuluaga FJ, Al-Hashimi I, Moody M, Lau CA, Peck AB, Brayer J, Humphreys-Beher MG, Dang H.
    Arthritis Rheum; 2001 Mar 27; 44(3):693-702. PubMed ID: 11263785
    [Abstract] [Full Text] [Related]

  • 31. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.
    Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, Schmidt M, Cotrim AP, Kriete M, Tak PP, Baum BJ.
    Oral Dis; 2006 Nov 27; 12(6):566-72. PubMed ID: 17054769
    [Abstract] [Full Text] [Related]

  • 32. A novel lacrimal gland autoantigen in the NOD mouse model of Sjögren's syndrome.
    Esch TR, Poveromo JD, Aikins MC, Levanos VA.
    Scand J Immunol; 2002 Mar 27; 55(3):304-10. PubMed ID: 11940237
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in nod mice.
    Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, Peck AB, Humphreys-Beher MG.
    Arthritis Rheum; 2000 Oct 27; 43(10):2297-306. PubMed ID: 11037890
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Inhibition of experimental Sjögren's syndrome through immunization with HSP60 and its peptide amino acids 437-460.
    Delaleu N, Madureira AC, Immervoll H, Jonsson R.
    Arthritis Rheum; 2008 Aug 27; 58(8):2318-28. PubMed ID: 18668586
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K, Fujita H, Tadano K, Takeuchi T, Murakami T, Saito I, Hayashi Y.
    Invest Ophthalmol Vis Sci; 2001 Jan 27; 42(1):101-10. PubMed ID: 11133854
    [Abstract] [Full Text] [Related]

  • 39. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
    Kong L, Robinson CP, Peck AB, Vela-Roch N, Sakata KM, Dang H, Talal N, Humphreys-Beher MG.
    Clin Exp Rheumatol; 1998 Jan 27; 16(6):675-81. PubMed ID: 9844759
    [Abstract] [Full Text] [Related]

  • 40. Alterations in nitric oxide synthase activity and expression in submandibular glands of NOD mice.
    Rosignoli F, Goren NB, Pérez Leirós C.
    Clin Immunol; 2001 Oct 27; 101(1):86-93. PubMed ID: 11580230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.